Maxderm s.r.o.
- Address
- lock Available on a paid plan
Maxderm s.r.o. - Dermatology Research Center
Maxderm s.r.o. is a specialized dermatology research center focused on advancing treatments for chronic inflammatory skin conditions. The center demonstrates particular expertise in conducting clinical trials for immune-mediated dermatological disorders, including both common and complex skin diseases requiring innovative therapeutic approaches.
- Chronic Spontaneous Urticaria (CSU) - evaluating novel biologics and targeted therapies for antihistamine-resistant cases
- Pediatric and Adult Moderate to Severe Chronic Plaque Psoriasis - investigating biologics across age groups
- Advanced immunological therapies including BTK inhibitors and mast cell targeting agents
The center has extensive experience with comparative effectiveness studies, including placebo-controlled and active comparator trials. Their research portfolio encompasses pharmacokinetic characterization, safety assessments, and efficacy evaluations using validated dermatological outcome measures such as PASI75, UAS7, ISS7, and PGA scores. Maxderm s.r.o. is equipped to conduct both short-term proof-of-concept studies and long-term extension trials extending beyond one year, demonstrating their capacity for comprehensive longitudinal safety and efficacy monitoring in dermatological populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Celldex Therapeutics Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Celldex Therapeutics Inc.2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Maxderm s.r.o.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Barzolvolimab | 2 | Unknown | 2025-04-04 | 2026-04-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.